Resumption of active recommendation of the human papillomavirus vaccine in Japan and future challenges for the National Immunization Program

Mugen UjiieVaccination Support Center, National Center for Global Health and Medicine, Tokyo, JapanCorrespondence[email protected]
View further author information

Article: 2090777 | Received 27 Apr 2022, Accepted 14 Jun 2022, Published online: 29 Jun 2022

Cite this article
https://doi.org/10.1080/21645515.2022.2090777
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF View EPUB EPUB

References

Normile D. Japan relaunches its HPV vaccination drive. For thousands of women, it may be too late. Science. 2022. doi:10.1126/science.abq2825.
Google Scholar
Ministry of Health, Labour, and Welfare of Japan. Summary of community health and health promotion project report in 2020 (Japanese). [accessed 2022 May 26]. https://www.mhlw.go.jp/toukei/saikin/hw/c-hoken/20/dl/kekka1.pdf.
Google Scholar
Ujiie M, Kitano T, Tsuzuki S. Changing trends in HPV vaccination in Japan. Hum Vaccin Immunother. 2022;18(1):1–3. doi:10.1080/21645515.2021.1986333.
PubMed Web of Science ®Google Scholar
Iversen OE, Miranda MJ, Ulied A, Soerdal T, Lazarus E, Chokephaibulkit K, Block SL, Skrivanek A, Nur Azurah AG, Fong SM, et al. Immunogenicity of the 9-valent HPV vaccine using 2-dose regimens in girls and boys vs a 3-dose regimen in women. Jama. 2016;316(22):2411–2421. doi:10.1001/jama.2016.17615.
PubMed Web of Science ®Google Scholar
Pan American Health Organization. One-dose human papillomavirus (HPV) vaccine offers solid protection against cervical cancer. [accessed 2022 Apr 24]. https://www.paho.org/en/news/11-4-2022-one-dose-human-papillomavirus-hpv-vaccine-offers-solid-protection-against-cervical?fbclid=IwAR2j5TIiINCwpnBZK9id7sxhqJwWjprLQtc-LaLUhT3OIgVAxST1J1Jrdew.
Google Scholar
United States Food & Drug Administration. Gardasil 9. [accessed 2022 May 26]. https://www.fda.gov/vaccines-blood-biologics/vaccines/gardasil-9.
Google Scholar
Dyne EAV, Henley SJ, Saraiya M, Thomas CC, Markowitz LE. Trends in human papillomavirus–associated cancers — United States, 1999–2015. Morb Mortal Wkly Rep. 2018;67(33):918–924. doi:10.15585/mmwr.mm6733a2.
PubMed Web of Science ®Google Scholar
National Institute of Infectious Disease of Japan. Fact sheet on 9-valent HPV vaccine. ( Japanese). 2021 Jan 31 [accessed 2022 Apr 24]. https://www.mhlw.go.jp/content/10906000/000770615.pdf.
Google Scholar
Simms KT, Hanley SJB, Smith MA, Keane A, Canfell K. Impact of HPV vaccine hesitancy on cervical cancer in Japan: a modelling study. Lancet Public Health. 2020;5(4):e223–34. doi:10.1016/S2468-2667(20)30010-4.
PubMed Web of Science ®Google Scholar
Tanaka S, Palmer M, Katanoda K. Trends in cervical cancer incidence and mortality of young and middle adults in Japan. Cancer Sci. 2022;113(5):1801–1807. doi:10.1111/cas.15320.
PubMed Web of Science ®Google Scholar
Tsuda K, Yamamoto K, Leppold C, Tanimoto T, Kusumi E, Komatsu T, Kami M. Trends of media coverage on human papillomavirus vaccination in Japanese newspapers. Clin Infect Dis. 2016;63:1634–1638.
PubMed Web of Science ®Google Scholar
Kimura M, Kuno-Sakai H, Yamazaki S, Yamada A, Hishiyama M, Kamiya H, Ueda K, Murase T, Hirayama M, Oya A, et al. Adverse events associated with MMR vaccines in Japan. Acta Paediatr Jpn. 1996;38:205–211.
PubMedGoogle Scholar
Morimoto N, Masuda S, Aso S, Kashio A, Kanda Y, Nakazawa M, Morita N, Nakagawa T, Nishizaki K. Nationwide survey of hearing loss caused by mumps during 2015–2016 in Japan. Nihon Jibiinkoka Gakkai Kaiho. 2018;121:1173–1180.
Google Scholar
National Institute of Infectious Diseases Japan. Mumps (infectious parotitis) in Japan, as of September 2016. Iasr. 2016;37:185–186. [accessed 2022 Apr 24]. https://www.niid.go.jp/niid/en/iasr-vol37-e/865-iasr/6843-440te.html.
Google Scholar
Kurane I. Evaluation of mouse brain-derived, inactivated Japanese encephalitis vaccine. Uirusu. 2005;55:307–312.
PubMedGoogle Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Resumption of active recommendation of the human papillomavirus vaccine in Japan and future challenges for the National Immunization Program

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Resumption of active recommendation of the human papillomavirus vaccine in Japan and future challenges for the National Immunization Program

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date